ITMI932189A1 - Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta - Google Patents

Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta

Info

Publication number
ITMI932189A1
ITMI932189A1 IT93MI002189A ITMI932189A ITMI932189A1 IT MI932189 A1 ITMI932189 A1 IT MI932189A1 IT 93MI002189 A IT93MI002189 A IT 93MI002189A IT MI932189 A ITMI932189 A IT MI932189A IT MI932189 A1 ITMI932189 A1 IT MI932189A1
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
compositions containing
cataract
treatment
acetyl carnosine
Prior art date
Application number
IT93MI002189A
Other languages
English (en)
Inventor
Mark A Babizhayev
Costa Edoardo Bozzo
Original Assignee
Bruschettini Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bruschettini Srl filed Critical Bruschettini Srl
Priority to ITMI932189A priority Critical patent/IT1270905B/it
Publication of ITMI932189A0 publication Critical patent/ITMI932189A0/it
Priority to AU78127/94A priority patent/AU7812794A/en
Priority to PCT/EP1994/003340 priority patent/WO1995010294A1/en
Publication of ITMI932189A1 publication Critical patent/ITMI932189A1/it
Application granted granted Critical
Publication of IT1270905B publication Critical patent/IT1270905B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invenzione ha per oggetto l'uso della N-acetilcarnosina per la fabbricazione di un medicamento utile nella prevenzione e terapia della cataratta e composizioni farmaceutiche contenenti N-acetilcarnosina come principio attivo.
ITMI932189A 1993-10-15 1993-10-15 Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta IT1270905B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI932189A IT1270905B (it) 1993-10-15 1993-10-15 Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
AU78127/94A AU7812794A (en) 1993-10-15 1994-10-10 Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
PCT/EP1994/003340 WO1995010294A1 (en) 1993-10-15 1994-10-10 Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI932189A IT1270905B (it) 1993-10-15 1993-10-15 Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta

Publications (3)

Publication Number Publication Date
ITMI932189A0 ITMI932189A0 (it) 1993-10-15
ITMI932189A1 true ITMI932189A1 (it) 1995-04-15
IT1270905B IT1270905B (it) 1997-05-13

Family

ID=11367036

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI932189A IT1270905B (it) 1993-10-15 1993-10-15 Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta

Country Status (3)

Country Link
AU (1) AU7812794A (it)
IT (1) IT1270905B (it)
WO (1) WO1995010294A1 (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2141483C1 (ru) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
NO993678L (no) * 1999-07-28 2001-01-29 Norsk Hydro As Fôr for salmonider
AUPR038200A0 (en) * 2000-09-26 2000-10-19 Beta Peptide Foundation Pty Ltd, The Compositions and methods for delaying, preventing, rejuvenating or reversing senescence
EP1551399A4 (en) 2002-09-30 2011-01-05 Mark A Babizhayev METHOD FOR THE TOPICAL TREATMENT OF EYE DISEASES AND COMPOSITION AND DEVICE FOR THIS TREATMENT
US20060116328A1 (en) * 2003-01-20 2006-06-01 Babizhayev Mark A Combined use of carnosinase inhibitor with l-carnosines and composition
WO2005041870A2 (en) 2003-10-24 2005-05-12 Ader Enterprises, Inc. Composition and method for the treatment of eye disease
US7776364B2 (en) 2006-03-24 2010-08-17 Advanced Scientific, Llc Non-surgical method for treating cataracts in mammals including man
CN106573957B (zh) 2014-07-31 2021-10-26 塞巴斯蒂安诺·舒托 由透明质酸和肌肽得到的衍生物
EP2993172B1 (en) 2014-09-04 2017-04-19 Nicox Science Ireland Nitric oxide donating carnosine compounds
IT202000014017A1 (it) 2020-06-11 2021-12-11 Fidia Farm Spa Nuovi derivati ottenuti da acido ialuronico e carnosina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5640613A (en) * 1979-09-13 1981-04-16 Nippon Chemiphar Co Ltd Novel type remedy for peptic ulcer
EP0436611A4 (en) * 1988-09-28 1992-03-11 Peptide Technology Ltd Compound and method for the retardation of collagen cross-linking
JPH07500580A (ja) * 1991-09-09 1995-01-19 ペプテック　リミテッド 糖尿病の合併症及び病因の処理方法

Also Published As

Publication number Publication date
AU7812794A (en) 1995-05-04
IT1270905B (it) 1997-05-13
WO1995010294A1 (en) 1995-04-20
ITMI932189A0 (it) 1993-10-15

Similar Documents

Publication Publication Date Title
YU13695A (sh) Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije
EA200201271A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
AU2003225617A1 (en) Thiadiazolylpiperazine derivatives useful for treating or preventing pain
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
EA199800357A1 (ru) Фармацевтические ангиостатические дипептидные композиции и способы их применения
BR0313148A (pt) Formulações de liberação controlada compreendendo lamotrigina
ES2092890T3 (es) Aplicacion del riluzol en el tratamiento de la enfermedad de parkinson y de los sindromes de parkinson.
GEP20002332B (en) Cefalosporin Derivatives
ES2062610T3 (es) Compuesto diarilico anti-ateroesclerotico.
ITMI932189A1 (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
BG106155A (en) Novel derivatives and analogues of galanthamin
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
ZA922910B (en) Heterocylic pharmaceutical compounds preparation and use
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
EA200400707A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
GEP20043377B (en) Pharmaceutical Complex
HUP9701293A2 (hu) Új, kellemetlen íztől mentes sók és ezeket tartalmazó gyógyszerkészítmények
GEP20053512B (en) S-Methyl-Dihydro-Ziprasidone for Treatment of Psychiatric and Ocular Disorders.
ATE293445T1 (de) Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
EA200401295A1 (ru) Статиновая терапия для усиления поддержания когнитивной функции
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
NO950177L (no) Farmakologisk aktive erivater

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971029